CAU
MLTX icon

Caxton Associates (UK)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Caxton Associates (UK)’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,880
Closed -$347K – 824
2025
Q1 		$347K Buy
+8,880
New +$347K 0.01% 586